Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has earned an average rating of “Buy” from the twelve analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have given a buy recommendation to the company. The […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned a consensus rating of “Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to […]
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) have been given an average recommendation of “Buy” by the twelve brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and nine have given a buy recommendation […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned an average recommendation of “Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have issued a buy recommendation on the […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned an average recommendation of “Buy” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price objective […]